Aurore Lagrange

Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial

Aurélien Dinh, Jacques Ropers, Clara Duran et al. · The Lancet · 2021 · 162 citations

Pharmacy, Pharmacotherapy, Antimicrobial Pharmacotherapy +13

Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial

Vincent Dubée, Pierre‐Marie Roy, Bruno Vielle et al. · Clinical Microbiology and Infection · 2021 · 43 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

High rates of off-label use in antibiotic prescriptions in a context of dramatic resistance increase: a prospective study in a tertiary hospital

Benjamin Davido, Frédérique Bouchand, Ruxandra Câlin et al. · International Journal of Antimicrobial Agents · 2016 · 22 citations

Pharmacy, Hospital Pharmacy, Pharmacotherapy +17

Factors Associated With Treatment Failure in Moderately Severe Community-Acquired Pneumonia

Aurélien Dinh, Clara Duran, Jacques Ropers et al. · JAMA Network Open · 2021 · 19 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Cost effectiveness of pneumococcal urinary antigen in Emergency Department: a pragmatic real-life study

Aurélien Dinh, Clara Duran, Benjamin Davido et al. · Internal and Emergency Medicine · 2016 · 13 citations

Pharmacy, Emergency Medicine, Pharmacoeconomics +16